Navigation Links
Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
Date:9/17/2012

Tumor biopsies of four patients following intravenous infusion showed four of four patients had local infection of JX-594 in tumor tissue while normal liver tissue was not affected, providing further evidence of JX-594's tumor selectivity and the ability to administer JX-594 intravenously.  Furthermore, after six or 12 weeks, 59 percent of patients had disease control as measured by modified RECIST and 75 percent of patients had objective responses by Choi criteria. 85 percent of patients had disease control by mRECIST and /or Choi response. 

JX-594: A Multi-Mechanistic Approach To Targeting Cancer
JX-594 is a proprietary, engineered oncolytic immunotherapy designed to selectively target and destroy cancer cells through three diverse mechanisms of action: 1) the lysis of cancer cells 2) the stimulation of an immune response against cancer cells, (i.e., active immunotherapy), and 3) the shutdown of the blood supply to tumors. Phase 1 and Phase 2 clinical trials in multiple cancer types to date have shown that JX-594, delivered either directly into tumors or intravenously, induces tumor shrinkage and/or necrosis and is well-tolerated (over 160 patients treated to date). Objective tumor responses have been demonstrated in a variety of cancers including liver, colon, kidney, lung cancer and melanoma. JX-594 has had a favorable, predictable and generally mild safety profile to date which includes flu-like symptoms that resolve in 24 to 48 hours.

JX-594 takes advantage of the natural attributes of poxviruses and was engineered to target and destroy solid tumors both systemically and locally.  The vaccinia virus backbone of JX-594 has been used safely in millions of people as part of a worldwide vaccination program. This strain naturally targets cancer cells due to common genetic abnormalities in cancer cells. JX-594 was engineered to enhance this cancer-selectivity by inactivating its thymidine kinase (TK) gene and encode the immunogenic
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
2. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
3. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
4. Mettler Toledo Presents In-depth Guidance to Comply with New USP Chapters 41 and 1251 on Balances Used for Quantitative Analysis in the Pharma QC Lab
5. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
6. Informex Global Pharma Sourcing 2012 Presents Key Strategies & Insight For Business Success
7. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
8. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
9. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
10. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
11. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... HUATULCO, Mexico , July 3, 2015 ... targeting the epidemics of hypertension, diabetes and thyroid disorders ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
(Date:7/3/2015)... 3, 2015  Obsidian HDS, the developer of PharmaShine ... for the management of data on pharmaceutical and device ... now includes the 2014 Open Payments General and Research ... June 30. The data disclosed on Open Payments for ... and providers totaling $6.49 billion and is the largest ...
(Date:7/2/2015)... July 3, 2015 Pharma ... 100% de participación en ZAO "Biocom" en Rusia ... la incursión de Lupin en el mercado farmacéutico ... en ventas, colocándolo como uno de los 10 ... Health). Durante más de una década, el mercado ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients in national lawsuits ... Cancer Lawsuit Center website. Just as the previous version did, the new website will ... lawsuit updates and ovarian cancer warning information. The site is routinely updated with news ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Yisrayl Hawkins, ... new article this week that he says will reveal biblical truth and expose popular ... “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the core of ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... located in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... opened June 19 in the Village at Bachman Lake, is located at:, 3701 W. Northwest ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants ... University of Minnesota, they knew it would save the university energy and maintenance ... choice: the total energy savings after installation was an impressive 89 percent, which ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech ... a technology expert and special reporter for NewsWatch, conducted the review and shared with ... market. , According to the U.S. Department of Energy, it’s very important to use ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... improved access to health education and benefits for ... seniors in communities across America, ... in Washington, D.C., CVS/pharmacy and the National Council on Aging,(NCOA) ... health and well-being of older Americans. Their joint,"Prescription for Better ...
... Batesville,Holdings, Inc., a wholly owned subsidiary of ... the present Batesville Casket Company,s funeral,services division, ... as Senior,Vice President Human Resources. He will ... human resources function for the new stand ...
... Accident Fund Insurance,Company of America has recognized Clark ... safe work environment. The company,recently surpassed 2 million ... 2006 the Michigan construction industry reported more,than 3,500 ... Construction,received the Gold Award from MIOSHA in 2005 ...
... ( http://www.nhs.uk ), the,digital ,front door, to the NHS, ... look after their foot health., Based on NHS ... find information about the importance of caring for your ... to treat them, plus how to,choose the correct footwear, ...
... Philadelphia City Council Acknowledges Department,s Anti-Violence,Program, ... Health and its partners were recognized today ... Injury Reporting and,Intervention System, or PIRIS, a ... Philadelphia., The system provides comprehensive intervention ...
... die from breast cancer each year because current treatments ... to stem the disease, warns Breast Cancer Campaign today. ... published today, 56 of the UKs most influential breast ... priorities for the greatest potential impact on patients. , ...
Cached Medicine News:Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 3Health News:Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources 2Health News:Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources 3Health News:Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources 4Health News:Accident Fund Recognizes Clark Construction Co. for 2 Million Hours without a Lost-Time Injury 2Health News:Department of Health Highlights Violence as a Public Health Issue 2Health News:Too many women still dying from breast cancer, says charity 2
Microwell EIA for detection of Calcitonin...
... Single Use Loading Units with Stainless Steel ... , ,Utilizing a disposable loading unit, ... clips to ligate the tissue within the ... the tissue between the two closed clips. ...
The ALLPORT and ALLPORT LS Endoscopic Rotating Multiple Clip Appliers have application for use on tubular structures or vessels. The tissue being ligated should be consistent with the size of the cli...
... Ligating Clip Applier is a reusable instrument ... and clips are designed to offer a ... structures where an absorbable ligating device is ... clip at the ligation site and facilitates ...
Medicine Products: